Upsher-Smith Laboratories
Manufacturing · Minnesota, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6701 Evenstad Dr N, Maple Grove, Minneso...Phone Number
(800) 654-2299Website
www.upsher-smith.comRevenue
$274.8 MillionIndustry
About Upsher-Smith Laboratories
Upsher-Smith Laboratories, LLC is a U.S. pharmaceutical company focused on manufacturing and marketing high-quality brand and generic medications across various therapeutic areas, particularly for migraine headaches and seizure disorders. The company is dedicated to improving patient health and lives through cost-effective therapies and strong industry relationships. Recently acquired by Bora Pharmaceuticals, Upsher-Smith aims to expand its product offerings and enhance patient care through strategic mergers and partnerships. With a commitment to innovation and employee development, Upsher-Smith continues to evolve in the healthcare industry.Explore more
SIC Code 28,283NAICS Code 32,325Show moreUpsher-Smith Laboratories Org Chart
Compare Similar Companies to Upsher-Smith Laboratories
Compare insights from companies similar to Upsher-Smith Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Upsher-Smith Laboratories Tech Stack
A closer look at the technologies used by Upsher-Smith Laboratories
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Upsher-Smith Laboratories
Sign Up For FreeTo access detailed company insights
Upsher-Smith Laboratories, LLC is a U.S. pharmaceutical company focused on manufacturing and marketing high-quality brand and generic medications across various therapeutic areas, particularly for migraine headaches and seizure disorders. The company is dedicated to improving patient health and lives through cost-effective therapies and strong indu... Read More